ÈÕ±¾avÉ«ÇéƬ

Scott T. Tagawa, MD, MS, FACP, FASCO, is a Professor of Medicine and Urology at ÈÕ±¾avÉ«ÇéƬ, and an Attending Physician at NewYork-Presbyterian – ÈÕ±¾avÉ«ÇéƬ Medical Center. After earning his BS from Georgetown University, Dr. Tagawa received his Medical Degree at the University of Southern California (USC) School of Medicine. After completing his Internship and Residency training at USC, he became Chief Resident and subsequently underwent fellowship training in Hematology and Medical Oncology, being appointed Chief Fellow for his final two years. Dr. Tagawa had the opportunity to train with international leaders in Genitourinary (GU) Oncology. In August 2005, he was appointed Assistant Professor of Medicine at Mount Sinai School of Medicine, serving as Associate Program Director for the Fellowship Training Program. As Director of Genitourinary (GU) Oncology for the Division of Hematology and Oncology and Director of Medical Oncology for the Deane Prostate Health and Research Center, Dr. Tagawa took the lead in developing genitourinary clinical trials. He was recruited to ÈÕ±¾avÉ«ÇéƬ (WCM)  in 2007. His research covers clinical and translational investigations in genitourinary tumors and thrombosis (blood clotting) in people with cancer. As the Medical Director of the Genitourinary Oncology Research Program, Dr. Tagawa leads clinical trials in the areas of prostate, kidney, and bladder cancer as well as the prevention and treatment of thrombosis with cancer. He specializes in drug development and theranostics in prostate cancer. Dr. Tagawa also serves as leader of the GU Disease Management Team and co-leader of the Experimental Therapeutics Program of the Meyer Cancer Center. He is the WCM principal investigator for the Alliance for Clinical Trials in Oncology (formerly CALGB), serving on the Board of Directors and as a funded member of the Genitourinary Committee. Additionally, he serves on the editorial boards of many journals, is a member of numerous national and international medical and scientific societies, and has been named on multiple “top doctor” award lists.

EDUCATION/TRAINING:

Georgetown University, Washington D.C. B.S.; 1993.

University of Southern California School of Medicine, Los Angeles, CA. M.D.; 1998.

Internship, Internal Medicine. University of Southern California Department of Medicine; June 1998 - June 1999.

Residency, Internal Medicine. University of Southern California Department of Medicine; July 1999 - June 2001.

Chief Resident, University of Southern California Department of Medicine, Los Angeles, CA.; July 2001 -June 2002.

Fellowship, Combined program in Hematology and Oncology. University of Southern California Department of Medicine, Divisions of Hematology and Oncology; July 2002 - June 2005.

Chief Fellow, Hematology; 2003-04.

Chief Fellow, Oncology; 2004-05.

ÈÕ±¾avÉ«ÇéƬ Graduate School of Medical Sciences, Masters of Science in Clinical Investigation; 2010.